Zhongguancun announced that Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of the company, received the “Notice of Termination of Drug Registration Application” issued by the State Drug Administration and agreed to withdraw the drug registration application for aminophen oxycodone tablets.

Zhongguancun announced that Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of the company, received the “Notice of Termination of Drug Registration Application” issued by the State Drug Administration and agreed to withdraw the drug registration application for aminophen oxycodone tablets.